U.S. investigators identified and quantitatively combined all available studies evaluating IgG trough levels and pneumonia incidence in PIDD patients receiving IVIG replacement therapy for hypogammaglobulinemia.
Specialty medications costing more than $600 per year are now classified under two new tiers of Medicare Part D drug benefit plan.
A team of investigators found that delivery of influenza vaccine at 60 percent of the standard dose by either IM or ID route elicited antibody responses generally similar to full-dose IM vaccination among healthy elderly persons.
Benlysta, an experimental lupus drug from GlaxoSmithKline chemically known as belimumab, significantly reduced patients’ symptoms in a recent drug trial.
Setpoint Medical, a startup company based in Boston, is developing a nerve stimulator designed to dampen the out-ofcontrol immune system that triggers autoimmune diseases such as inflammatory bowel disease and rheumatoid arthritis.
Teva Pharmaceutical Industries Ltd.is investigating whether its drug Laquinimod, which is in a Phase III clinical trial for treating multiple sclerosis, also is suitable for treating lupus.
In March 2010, the federal vaccines court ruled in three separate cases that the mercury-containing preservative thimerosal does not cause autism.
New data reinforce the idea that IgMinduced, complement-mediated nodal injury of peripheral motor nerves generates conduction block and accounts for muscle weakness.
FlexCare Clinical Research LLC is a new niche clinical service provider focused on providing study visits in the home or alternative site settings via a network of skilled clinicians.
A new study discovered evidence that Parkinson’s disease may have an infectious or autoimmune origin.
Amsterdam Molecular Therapeutics has begun a Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B.
According to the U.S. Centers for Disease Control and Prevention, more U.S. teens are getting recommended vaccines against certain cancers, meningitis and infectious diseases.